Erasca is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Erasca is a startup founded in 2018 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Erasca is a clinical-stage oncology company focused on discovering, developing, and commercializing new therapies for patients with cancer. They aim to address unmet medical needs by advancing a pipeline of targeted treatments.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.